The hotspotting technique that Camden Coalition of Healthcare Providers uses to care for complex patients shifts away from breaking people into segments based on disease, and looks at the whole make up of a person, considering every disease or social complexity that may be in effect, explained Renee Murray, associate clinical director of Care Management Initiatives at Camden Coalition.
The hotspotting technique that Camden Coalition of Healthcare Providers uses to care for complex patients shifts away from the practice in traditional medicine of breaking people into segments based on disease and looks at the whole make up of a person and considering every disease or social complexity that may be affecting that person's healthcare, Renee Murray, associate clinical director of Care Management Initiatives at Camden Coalition, explained at the ACO & Emerging Healthcare Delivery Coalition Fall Live Meeting in Philadelphia, Pennsylvania.
Transcript
How does hotspotting improve care for complex patients compared with traditional medicine?
So traditional medicine is more so about breaking people into silos or segments, whether you're living with diabetes or living with congestive heart failure or chronic obstructive pulmonary disease (COPD) or end-stage renal disease—that's how our healthcare system makes interventions or treats people or has conversations with people in those silos. So if you are living with diabetes, I'm going to talk to you about diet and blood sugar and exercise and that management. And the shift is, and the paradigm that we're working out of the hotspotting paradigm is looking at complex patients in complex systems.
So the shift is, we're not just segmenting the disease, we are embracing multiple diseases that the person might be living with—the person might be living with COPD, congestive heart failure, unmanaged schizophrenia, and depression, in addition to experiencing homelessness. The hotspotting paradigm is shifting, saying, "We're looking at the holistic approach, we're looking at the whole entire picture of the patient, and we're focusing on all of it." We're not just going to laser in on one disease state, we're taking everything that's making up this person into account, and we're going to figure out, how do we plug them into a complex system, but with resources that already exist.
The main difference is the shift of not being laser focused on the disease, pulling back 50,000 feet and looking at the whole make up of the person.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More